Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
Background: Efforts to understand the impact of SARS-CoV-2 variants, vaccine status, and treatment on the development and persistence of Long COVID have intensified. Methods: We report 4 sequential cases from a post-COVID cohort study demonstrating variability in outcomes following differentiall...
Main Authors: | Michael Peluso, Khamal Anglin, Matthew S. Durstenfeld, Jeffrey N. Martin, J. Daniel Kelly, Priscilla Y. Hsue, Timothy J. Henrich, Steven G. Deeks |
---|---|
Format: | Article |
Language: | English |
Published: |
Case Western Reserve University
2022-06-01
|
Series: | Pathogens and Immunity |
Subjects: | |
Online Access: | https://www.paijournal.com/index.php/paijournal/article/view/518 |
Similar Items
-
Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir—A Literature Review
by: Sydney Paltra, et al.
Published: (2024-01-01) -
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
by: Karolina Akinosoglou, et al.
Published: (2022-11-01) -
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and FutunaResearch in context
by: Antoine Brault, et al.
Published: (2023-01-01) -
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
by: Yuan-Pin Hung, et al.
Published: (2022-02-01) -
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019
by: Chie Yamamoto, et al.
Published: (2024-04-01)